Welltower (NYSE:WELL) Price Target Raised to $170.00

Welltower (NYSE:WELL) had its price target hoisted by Mizuho from $141.00 to $170.00 in a research note released on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the real estate investment trust’s stock.

A number of other brokerages have also commented on WELL. Jefferies Financial Group raised shares of Welltower from a “hold” rating to a “buy” rating and upped their price objective for the company from $132.00 to $147.00 in a research report on Thursday, January 2nd. Scotiabank upped their price objective on shares of Welltower from $165.00 to $166.00 and gave the company a “sector outperform” rating in a research report on Thursday, March 6th. Wells Fargo & Company upped their price objective on shares of Welltower from $140.00 to $158.00 and gave the company an “equal weight” rating in a research report on Monday, March 10th. Royal Bank of Canada raised shares of Welltower from a “sector perform” rating to an “outperform” rating and upped their price objective for the company from $146.00 to $168.00 in a research report on Friday, February 28th. Finally, Bank of America upped their price objective on shares of Welltower from $221.00 to $242.00 and gave the company a “buy” rating in a research report on Tuesday, February 18th. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, Welltower presently has an average rating of “Moderate Buy” and an average price target of $156.46.

Welltower Trading Down 0.7 %

NYSE WELL opened at $147.77 on Tuesday. Welltower has a twelve month low of $87.87 and a twelve month high of $158.55. The company has a debt-to-equity ratio of 0.48, a quick ratio of 4.22 and a current ratio of 4.22. The stock has a market cap of $94.76 billion, a price-to-earnings ratio of 94.72, a PEG ratio of 2.87 and a beta of 1.20. The firm’s 50 day moving average price is $143.06 and its two-hundred day moving average price is $134.44.

Welltower (NYSE:WELL) last posted its quarterly earnings results on Tuesday, February 11th. The real estate investment trust reported $1.13 EPS for the quarter, beating the consensus estimate of $0.40 by $0.73. Welltower had a net margin of 11.91% and a return on equity of 3.15%. Equities analysts anticipate that Welltower will post 4.88 EPS for the current year.

Welltower Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, March 6th. Stockholders of record on Tuesday, February 25th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Tuesday, February 25th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.81%. Welltower’s payout ratio is 171.79%.

Institutional Trading of Welltower

Several institutional investors and hedge funds have recently modified their holdings of WELL. Laurel Wealth Advisors LLC acquired a new position in Welltower in the 4th quarter worth about $25,000. Roxbury Financial LLC acquired a new position in Welltower in the 4th quarter worth about $26,000. Sierra Ocean LLC acquired a new position in Welltower in the 4th quarter worth about $28,000. Versant Capital Management Inc increased its holdings in Welltower by 165.5% in the 4th quarter. Versant Capital Management Inc now owns 300 shares of the real estate investment trust’s stock worth $38,000 after purchasing an additional 187 shares in the last quarter. Finally, First Command Advisory Services Inc. acquired a new position in Welltower in the 4th quarter worth about $50,000. 94.80% of the stock is currently owned by institutional investors.

Welltower Company Profile

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.